NCT03910699

Brief Summary

This trial aims to assess safety and efficacy of three-row circular staplers compared to two-row surgical stapllers in short-term and long-term perspective in patients with rectal cancer undergoing low anterior resection with stapled colorectal anastomosis. All the patients will undergo a low anterior resection. In a half of patients a colorectal anastomosis will be created with a three-row surgical circular stapler. In another half of patients a colorectal anastomosis will be created with a two-row surgical circular stapler.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 10, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

April 10, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2020

Completed
Last Updated

October 8, 2019

Status Verified

October 1, 2019

Enrollment Period

6 months

First QC Date

April 8, 2019

Last Update Submit

October 6, 2019

Conditions

Keywords

AnastomosisAnastomotic leakageRectal cancerTotal mesorectal excisionLow anterior resectionAnastomotic leakColorectal anastomosisThree-row stapler

Outcome Measures

Primary Outcomes (1)

  • Anastomotic leakage rate

    The rate of colorectal anastomosis dehiscence documented with an X-ray and/or CT scan

    6 weeks

Secondary Outcomes (12)

  • Operating time

    1 day

  • Circular stapler misfunction rate

    1 day

  • Anastomotic bleeding rate

    30 days

  • Re-intervention rate

    6 weeks

  • Early postoperative complications rate

    30 days

  • +7 more secondary outcomes

Study Arms (2)

Two-row anastomosis

ACTIVE COMPARATOR

Colorectal anastomosis is created with a two-row circular surgical stapler

Device: Two-row circular stapler

Three-row anastomosis

EXPERIMENTAL

Colorectal anastomosis is created with a three-row circular surgical stapler

Device: Three-row circular stapler

Interventions

Para-aortic lymph node dissection, inferior mesenteric artery skeletonisation and ligation below left colic artery origin, nerve-preserving total mesorectal excision, rectum division with a linear stapler, sigmoid colon division and circular stapler envil fixation with a purse-string suture, end-to-end colorectal anastomosis creation with a three-row circular stapler, defunctioning colostomy is performed.

Also known as: MirusTM Disposable Circular Stapler 3 Row 29 (MCS-29R3)
Three-row anastomosis

Para-aortic lymph node dissection, inferior mesenteric artery skeletonisation and ligation below left colic artery origin, nerve-preserving total mesorectal excision, rectum division with a linear stapler, sigmoid colon division and circular stapler envil fixation with a purse-string suture, end-to-end colorectal anastomosis creation with a two-row circular stapler, defunctioning colostomy is performed.

Also known as: Ethicon 29mm Curved Intraluminal Stapler (CDH29A)
Two-row anastomosis

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Provision of signed and dated informed consent form
  • Stated consent to comply with all study procedures and availability for the duration of the study
  • Male or female
  • For females of reproductive potential: not pregnant at the time of screening
  • For males of reproductive potential: use of condoms or other methods to ensure effective contraception with partner
  • Histologically proven primary rectal adenocarcinoma located within 5 to 15 cm from anal verge not involving internal and/or external sphincter muscle
  • Current use of antiplatelet drugs, acetylsalicylic acid or anticoagulants within 7 days prior to intervention
  • Unresectable tumour, inability to perform a TME with colorectal anastomosis, inability to complete R0 resection or presence of T4b tumour necessitating a multi-organ resection
  • Inability to save the left colic artery
  • Diameter of rectal lumen is unable to contain the working part of the stapler
  • Infection requiring antibiotic treatment within 30 days prior to intervention
  • Anal incontinence prior to surgery (Wexner Continence Grading Scale \>=10)
  • Significant comorbidities - ASA \> III

You may not qualify if:

  • Patient lost for observation
  • Inability to complete all the trial procedures
  • Death due to causes unrelated to anastomotic leak in early postoperative period
  • \. Current smoker or tobacco use within \<specify timeframe\> 9. Patient wants to withdraw from the clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Colorectal and Minimally Invasive Surgery - I.M. Sechenov First Moscow State Medical University

Moscow, 119435, Russia

RECRUITING

Related Publications (1)

  • Nekliudov NA, Tsarkov PV, Tulina IA. Uni-center, patient-blinded, randomized, 12-month, parallel group, noninferiority study to compare outcomes of 3-row vs 2-row circular staplers for colorectal anastomosis formation after low anterior resection for rectal cancer. Medicine (Baltimore). 2019 Jun;98(24):e15978. doi: 10.1097/MD.0000000000015978.

MeSH Terms

Conditions

Anastomotic LeakRectal Neoplasms

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Petr Tsarkov, MD

    Russian Society of Colorectal Surgeons

    STUDY DIRECTOR

Central Study Contacts

Inna Tulina, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Oncologic Colorectal Surgery Department, Clinic of Colorectal and Minimally Invasive Surgery

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 10, 2019

Study Start

April 10, 2019

Primary Completion

October 1, 2019

Study Completion

October 1, 2020

Last Updated

October 8, 2019

Record last verified: 2019-10

Locations